Provided by Tiger Trade Technology Pte. Ltd.

Cellmid

0.056
0.000
Volume:- -
Turnover:3.68K
Market Cap:12.38M
PE:-3.29
High:0.056
Open:0.056
Low:0.056
Close:0.056
52wk High:0.056
52wk Low:0.056
Shares:221.00M
Float Shares:146.14M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.017
EPS(LYR):-0.024
ROE:-37.59%
ROA:-14.43%
PB:1.19
PE(LYR):-2.33

Loading ...

Company Profile

Company Name:
Cellmid
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.